• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. PENUMBRA SYSTEM ACE 68 REPERFUSION CATHETER; NRY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. PENUMBRA SYSTEM ACE 68 REPERFUSION CATHETER; NRY Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Embolus (1830)
Event Date 02/05/2017
Event Type  Injury  
Manufacturer Narrative
The product was not returned for evaluation.From the information provided, there is no indication that there was any device malfunction, nonconformance, or misuse that contributed to the reported events.Distal embolization event is a known and anticipated complications with these types of procedures and are noted in the device labeling.Therefore, the reported distal embolization events are considered anticipated procedural complications.The product lot number was not provided, therefore, the manufacturing records could not be reviewed.This report is associated with mfr report number: 3005168196-2017-01634.The hospital discarded the device.
 
Event Description
The patient underwent a thrombectomy procedure on (b)(6) 2017 in the middle cerebral artery (mca) using a penumbra system ace 68 reperfusion catheter (ace68) and a penumbra system 3max reperfusion catheter (3maxc).After the thrombus was aspirated using the ace68 and the 3maxc, a peripheral thrombus was seen at the bifurcation of the m2 segment.There was persistent flow around this distal thrombus, therefore, it was decided to not pursue further intervention to remove the thrombus.A 24-hour follow-up computed tomography (ct) scan did not reveal any change in the infarction area; therefore, the patient was discharged home on (b)(6) 2017 with a national institutes of health stroke scale (nihss) score of 0.The investigator reported that the event was a non-serious adverse event unrelated to the ace68 and 3maxc, and definitely related to the angiographic procedure.On (b)(6) 2017, this non-serious adverse event was adjudicated to be possibly related to the ace68, 3maxc, angiographic procedure, and index stroke.The outcome was considered to be resolved the same day, (b)(6) 2017.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENUMBRA SYSTEM ACE 68 REPERFUSION CATHETER
Type of Device
NRY
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key6891847
MDR Text Key87292957
Report Number3005168196-2017-01633
Device Sequence Number1
Product Code NRY
Combination Product (y/n)N
Reporter Country CodeSZ
PMA/PMN Number
K161640
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 08/29/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/25/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/29/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age76 YR
-
-